|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | |
| A61K 31/00 | |||
| A61P 9/04 | |||
| A61K 9/20 |
| (11) | Number of the document | 2968180 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14715519.6 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/027061 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/152198 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361785492 P | 2013-03-14 | US |
| (72) |
CALDWELL, Brett, US
|
| (73) |
Amgen Inc.,
1 Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | HETEROCYCLIC COMPOUNDS AND THEIR USES |
| HETEROCYCLIC COMPOUNDS AND THEIR USES |